Impact BioMedical Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 16 →InsidersNo open-market buys. 2 insiders sold $57,764, 0 of 3 sales on a 10b5-1 plan.→HoldersGeode 1.1%Vanguard 0.8%State Street 0.6%→
From the filings
Figures
- Revenue
- $35,000last 12 months
- Net income
- $789,000last 12 months
- Operating cash flow
- −$1.7Mlast 12 months
- Cash and equivalents
- $20,000at the last balance sheet
- Shares outstanding
- 107.8M shareson issue